Fenoterol is a β adrenoreceptor agonist. It is classed as sympathomimetic β2 agonist and an inhaled bronchodilator asthma medication. Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N. It was patented in 1962 and came into medical use in 1971 but, in the 1980s, concerns emerged about its safety and its use being associated with an increased risk of death (see below). Adverse effects and toxicity. Fenoterol is a short-acting β2 agonist that also stimulates β1 receptors.
https://en.wikipedia.org/wiki/Fenoterol
Fenoterol is a β adrenoreceptor agonist. It is classed as sympathomimetic β2 agonist and an inhaled bronchodilator asthma medication. Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N. It was patented in 1962 and came into medical use in 1971 but, in the 1980s, concerns emerged about its safety and its use being associated with an increased risk of death (see below). Adverse effects and toxicity. Fenoterol is a short-acting β2 agonist that also stimulates β1 receptors.
